All Articles

Effects of FAP⁺ cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4⁺ T cell polarization in gastric cancer

Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression

Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy

Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC

Modeling methods of different tumor organoids and their application in tumor drug resistance research

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

MicroRNA-mediated autophagy regulation in thyroid cancer drug resistance

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies

Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors

Acquired resistance to molecularly targeted therapies for cancer

PER2 expression and cellular localization play a critical role in tumor aggressiveness and drug resistance in an in vitro model of hepatocellular carcinoma

ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC

Advances in the application of patient-derived xenograft models in acute leukemia resistance

FGFR1 overexpression promotes resistance to PI3K inhibitor alpelisib in luminal breast cancer cells through receptor tyrosine kinase signaling-mediated activation of the estrogen receptor

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness